R&D Systems™ Recombinant Human IL-13 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human IL-13 Protein is derived from E. coli. The Recombinant Human IL-13 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: AAK53823
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2um filtered solution in PBS with BSA as a carrier protein.
• Gene ID (Entrez): 3596
• Molecular Weight (g/mol): 12.3 kDa
• Name: IL-13
• Quantity: 10 μg
• Source: <EM>E. coli</EM>-derived human IL-13 protein Gly21-Asn132
• Storage Requirements: Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution
• Regulatory Status: RUO
• Endotoxin Concentration: <0.01 EU / 1 ug of the protein by the LAL method.
• Gene Symbol: IL13
• Conjugate: Unconjugated
• Cross Reactivity: IL-13
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100 ug/mL in PBS containing (at least 0.1% human or bovine serum albumin.)
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.